IGF::OT::IGF: Psycho Social Project with IOM (NAS)

医学研究所（IOM）建议建立一个特别委员会，寻求将临床科学与绩效测量结合起来，为根据最新的有效性科学为社会心理治疗开发质量测量方法开辟一条前进的道路。目前，社会心理治疗的验证过程和覆盖范围的确定是高度可变的。此外，还有许多学科和层次的培训声称可以提供有效的社会心理治疗。用于确定覆盖范围的科学证据水平、所使用的研究类型和结果测量方法，以及确定必要剂量和治疗持续时间所需的证据都存在差异。此外，没有标准来确保治疗的保真度，例如，基于提供者的培训或提供者的绩效指标。因此，消费者和付款人很难理解他们购买的是什么。这种不确定性使购买者对一般心理社会服务的价值产生怀疑。

The Institute of Medicine (IOM) proposes to establish an ad hoc committee that would seek to marry clinical science with performance measurement to develop a path forward for developing quality measures for psychosocial therapies that are informed by the latest science on effectiveness. The process by which psychosocial therapies are currently validated, and coverage determinations are made, is highly variable. In addition there are a wide range of disciplines and levels of training that claim to provide effective psychosocial treatments. Variation exists in the levels of scientific evidence used to make coverage determinations, the types of studies and outcome measures used, and the evidence needed to determine the necessary dose and duration of treatments. Further, there are no standards in place to ensure treatment fidelity based, for example, on providers¿ training or performance metrics for providers. As a result, it is difficult for consumers and payers to understand what they are buying. This uncertainty creates skepticism among purchasers regarding the value of the average psychosocial service.